Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THRIVE: Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events

NCT06863480 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT06863480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06863480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THRIVE: Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
Lead sponsor
University of Florida
Phase
Phase 1
Overall status
Recruiting
Start date
March 2, 2026
Completion date
October 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage, delayed cerebral ischemia